Nov 10, 2020 / 10:00PM GMT
Gretel Janu - Crédit Suisse AG - Research Division - Research Analyst
All right. Hi, everyone. So my name is Gretel Janu. So I've got here, Mick Farrell, CEO of ResMed; and Dave Pendarvis, CAO of ResMed.
So Mick, David, thank you very much for your time today for joining our conference. Now it's great to have you here virtually.
Questions and Answers:
Gretel Janu - Crédit Suisse AG - Research Division - Research AnalystSo I think to start us off, Mick, do you want to start off to give us an update as to how the business has performed during COVID? A quick highlight of the latest results, given they were just a couple of weeks ago, and then we'll jump into some of the questions.
Michael J. Farrell - ResMed Inc. - CEO & Director
Yes. Sounds good, Gretel. I'll do just a very brief maybe 3-minute intro, and then allow the bulk of the time, Gretel, for you to facilitate Q&A from the team that's on.
So look, incredible 2020 here with